Follicular Lymphoma

About
Mappings

NCI Thesaurus: Follicular Lymphoma (coding:ncit:C3209)

OncoTree: Follicular Lymphoma (coding:oncotree:FL)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) EZH2 p.Y646N Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.Y646F Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.Y646H Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.Y646S Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.Y646C Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.A682G Follicular Lymphoma Tazemetostat
FDA (2) EZH2 p.A692V Follicular Lymphoma Tazemetostat
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Chlorambucil, Mitoxantrone, Prednisolone, Rituximab
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Interferon Alpha, Prednisolone, Rituximab
HSE (4) CD20 + Follicular Lymphoma Rituximab
HSE (2) CD20 + Follicular Lymphoma Bendamustine, Obinutuzumab
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Obinutuzumab, Prednisolone, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Obinutuzumab, Prednisolone, Vincristine